HLA-G and cancer: In examining the presence or absence of HLA class I expression in MSI-high cancers in the context of the tumor stage, and the presence or absence of distant metastases, intuitively one may suggest that the loss of β2 microglobulin and/or class I expression would be increased in tumors that have metastasized.